Login / Signup

Secukinumab does not impair the immunogenic response to the influenza vaccine in patients.

Patricia RichiMaría Dolores MartínFernando de OryRosa Gutiérrez-LarrayaInmaculada CasasAna María Jiménez-DíazFernando CavaSantiago Muñoz-Fernandez
Published in: RMD open (2019)
In our study, secukinumab has no effect on the immunogenic response to the influenza vaccine.
Keyphrases
  • end stage renal disease
  • ankylosing spondylitis
  • newly diagnosed
  • chronic kidney disease
  • systemic lupus erythematosus
  • patient reported outcomes
  • patient reported